Zobrazeno 1 - 10
of 183
pro vyhledávání: '"Konrad H. Stopsack"'
Autor:
Sai Harisha Rajanala, Romina Ghale, Subhiksha Nandakumar, Kalyani Chadalavada, Gwo-Shu Mary Lee, Konrad H. Stopsack, Yu Chen, Gouri J. Nanjangud, Goutam Chakraborty, Philip W. Kantoff
Publikováno v:
PLoS ONE, Vol 19, Iss 4 (2024)
Externí odkaz:
https://doaj.org/article/80b879e25c0b4a39bcc680a45637b531
Autor:
Yuki Yoshikawa, Konrad H. Stopsack, Xin Victoria Wang, Yu‐Hui Chen, Ying Z. Mazzu, Foster Burton, Goutam Chakraborty, Sai Harisha Rajanala, Rahim Hirani, Subhiksha Nandakumar, Gwo‐Shu Mary Lee, David Frank, Elai Davicioni, Glenn Liu, Michael A. Carducci, Haruhito Azuma, Philip W. Kantoff, Christopher J. Sweeney
Publikováno v:
Molecular Oncology, Vol 16, Iss 22, Pp 3994-4010 (2022)
Loss of the histone demethylase KDM5D (lysine‐specific demethylase 5D) leads to in vitro resistance of prostate cancer cells to androgen deprivation therapy (ADT) with and without docetaxel. We aimed to define downstream drivers of the KDM5D effect
Externí odkaz:
https://doaj.org/article/f3e5c6df0fe14e4b96ddc7e70c0635e6
Autor:
Lorelei A. Mucci, Jacob Vinson, Theresa Gold, Travis Gerke, Julie Filipenko, Rebecca M. Green, Simon G. Anderson, Simone Badal, Anders Bjartell, Kim N. Chi, Ian D. Davis, Deborah Enting, André P. Fay, John Lazarus, Joaquin Mateo, Ray McDermott, Folakemi T. Odedina, David Olmos, Aurelius Omlin, Ademola A. Popoola, Camille Ragin, Robin Roberts, Kjell M. Russnes, Charles Waihenya, Konrad H. Stopsack, Terry Hyslop, Paul Villanti, Philip W. Kantoff, Daniel J. George
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
PURPOSETo describe a newly established international registry recruiting diverse patients with advanced prostate cancer across academic and community practices to address unmet needs in this population.PATIENTS AND METHODSInitiated in 2017, IRONMAN (
Externí odkaz:
https://doaj.org/article/c2ac1375880a4f8296dca71b57375939
Autor:
Konrad H Stopsack, Svitlana Tyekucheva, Molin Wang, Travis A Gerke, J Bailey Vaselkiv, Kathryn L Penney, Philip W Kantoff, Stephen P Finn, Michelangelo Fiorentino, Massimo Loda, Tamara L Lotan, Giovanni Parmigiani, Lorelei A Mucci
Publikováno v:
eLife, Vol 10 (2021)
Tissue microarrays (TMAs) have been used in thousands of cancer biomarker studies. To what extent batch effects, measurement error in biomarker levels between slides, affects TMA-based studies has not been assessed systematically. We evaluated 20 pro
Externí odkaz:
https://doaj.org/article/5d3559e372204133ba3415106d7b03ea
Autor:
Yiwen Zhang, Konrad H. Stopsack, Kana Wu, Mingyang Song, Lorelei A. Mucci, Edward Giovannucci
Publikováno v:
Journal of Urology. 209:549-556
Biological and experimental evidence support restoration of normal zinc levels in malignant prostate cells as a promising prostate cancer treatment, yet the influence of zinc supplementation after diagnosis on prostate cancer survival in a human popu
Autor:
Konrad H. Stopsack, Lorelei A. Mucci, Shelley S. Tworoger, Jae H. Kang, A. Heather Eliassen, Walter C. Willett, Meir J. Stampfer
Publikováno v:
Epidemiology. 34:389-395
Autor:
Chaoran Ma, Yinglu Zhou, Giuseppe Nicolò Fanelli, Konrad H. Stopsack, Michelangelo Fiorentino, Giorgia Zadra, Lorelei A. Mucci, Massimo Loda, Svitlana Tyekucheva, Kathryn L. Penney
Publikováno v:
Molecular Cancer Research. 21:253-260
Prostate cancer has a heterogeneous prognosis. Most previous studies have focused on the identification of prognostic biomarkers in the prostate cancer tumor. However, it is increasingly recognized that the tumor microenvironment contributes to prost
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 32:585-587
Metastases are the main cause of morbidity and mortality from solid tumors. Surprisingly, population-based cancer registries in various countries, including the National Cancer Institute's Surveillance, Epidemiology, and End Results program in the Un
Autor:
Aram Ghalali, Liangzhe Wang, Konrad H. Stopsack, James M. Rice, Shulin Wu, Chin-Lee Wu, Bruce R. Zetter, Michael S. Rogers
Publikováno v:
Experimental & Molecular Medicine. 54:1713-1726
The transcript encoding Antizyme Inhibitor 1 (AZIN1) is frequently edited in various cancers, and this editing is associated with enhanced tumor aggressiveness. After comparison of wild-type AZIN1 (wtAZIN1) and edited AZIN1 (edAZIN1, which contains a
Autor:
Yuki Yoshikawa, Konrad H. Stopsack, Xin Victoria Wang, Yu‐Hui Chen, Ying Z. Mazzu, Foster Burton, Goutam Chakraborty, Sai Harisha Rajanala, Rahim Hirani, Subhiksha Nandakumar, Gwo‐Shu Mary Lee, David Frank, Elai Davicioni, Glenn Liu, Michael A. Carducci, Haruhito Azuma, Philip W. Kantoff, Christopher J. Sweeney
Publikováno v:
Molecular Oncology. 16:3994-4010
Loss of the histone demethylase KDM5D (lysine-specific demethylase 5D) leads to in vitro resistance of prostate cancer cells to androgen deprivation therapy (ADT) with and without docetaxel. We aimed to define downstream drivers of the KDM5D effect.